The results of the present work indicate that our in vitro BME cells system could be of value for the evaluation of immunomodulatory treatments aimed to improve the TLR4-mediated innate immune response in the bovine mammary gland and the protection against infections by Gram-negative pathogens. The gene discussed is TLR4; the disease is infection.